NEW YORK (GenomeWeb) – St. Jude Children's Research Hospital has appointed James Downing as its new CEO, effective July 15. Downing most recently served as deputy director, executive vice president, and scientific director of the hospital. He will succeed William Evans, who is retiring as CEO after 10 years and returning full time to his pharmacogenomics research program at St. Jude.


EpiCypher, an epigenomics products and services firm, has named Sam Tetlow to be its first CEO and to serve on the board of directors.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.